Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
rabea.mecklenbrauck@imm.ox.ac.uk

Research groups

Vyas Group: Biology and Treatment of Human Myeloid Cancers

Rabea Mecklenbrauck

Postdoctoral Researcher

Recent publications

Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Mecklenbrauck R. et al, (2026), Leukemia

Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.

Turkalj S. et al, (2026), Blood, 147, 613 - 632

Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study.

Hernández-Sánchez A. et al, (2026), Leukemia

Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia.

Mecklenbrauck R. et al, (2025), Leukemia, 39, 1773 - 1777

Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma.

Mecklenbrauck R. et al, (2025), Leuk Res Rep, 24

More publications